Unknown

Dataset Information

0

Who 'nose', is it the angiotensin receptor neprilysin inhibitor?: a case series of persistent nasal pruritus in heart failure patients receiving sacubitril/valsartan.


ABSTRACT:

Background

Sacubitril/valsartan is approved for the treatment of chronic heart failure with reduced left ventricular ejection fraction of ≤40% to decrease mortality and morbidity. Nasal pruritus is not a recognized adverse effect in the product information. In this case series, we encountered three patients who presented with nasal pruritus that improved after discontinuation of sacubitril/valsartan.

Case summary

Three patients aged 58-73 years-old presented with pruritus at the nasal septum post-initiation of sacubitril/valsartan. The pruritus did not subside despite the use of anti-histamines. Within 3-6 months, all individuals discontinued sacubitril/valsartan with complete resolution of their nasal pruritus.

Discussion

Many physicians may not aware of this unusual but reversible adverse effect of sacubitril/valsartan. Despite the positive prognostic value of sacubitril/valsartan, the constant nasal pruritus had impacted the quality of life of our patients, leading them to discontinue sacubitril/valsartan permanently.

SUBMITTER: Gan J 

PROVIDER: S-EPMC8717058 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Who 'nose', is it the angiotensin receptor neprilysin inhibitor?: a case series of persistent nasal pruritus in heart failure patients receiving sacubitril/valsartan.

Gan Jaclyn J   Rheault Haunnah H   Wong Yee Weng YW  

European heart journal. Case reports 20211211 12


<h4>Background</h4>Sacubitril/valsartan is approved for the treatment of chronic heart failure with reduced left ventricular ejection fraction of ≤40% to decrease mortality and morbidity. Nasal pruritus is not a recognized adverse effect in the product information. In this case series, we encountered three patients who presented with nasal pruritus that improved after discontinuation of sacubitril/valsartan.<h4>Case summary</h4>Three patients aged 58-73 years-old presented with pruritus at the n  ...[more]

Similar Datasets

| S-EPMC6857845 | biostudies-literature
| S-EPMC11010079 | biostudies-literature
| S-EPMC9575392 | biostudies-literature
| S-EPMC7799406 | biostudies-literature
| S-EPMC8837825 | biostudies-literature
| S-EPMC5684857 | biostudies-literature
| S-EPMC5834447 | biostudies-literature
| S-EPMC5013095 | biostudies-literature
| S-EPMC8121351 | biostudies-literature
| S-EPMC8710618 | biostudies-literature